MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote (indian pharma)
- STRIDES PHARMA SCIENCE
STRIDES PHARMA SCIENCE Share Price (PLLB)
Here is the latest stock price and chart of STRIDES PHARMA SCIENCE. For more details, see the STRIDES PHARMA SCIENCE company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Revealed: How to Get Rich with Just 3 Stocks
| Live BSE Quotes | Aug 7, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)524.05 | Open (Rs) 526.00 | High (Rs) 537.75 | Low (Rs) 514.75 |
| % Change-0.18 | Volume 221,920 | Value (Rs) 116,572,711 | 52-Week H/L 552.90 / 271.00 |
| Live NSE Quotes | Aug 7, 2020 (Close) | ||
|---|---|---|---|
| Price (Rs)523.80 | Open (Rs) 527.45 | High (Rs) 537.65 | Low (Rs) 514.10 |
| % Change-0.29 | Volume 1,935,313 | Value (Rs) 1,018,423,957 | 52-Week H/L 552.90 / 268.00 |
| Change | |||||
|---|---|---|---|---|---|
| 1 Day -0.18% | 1 Month 27.69% | 3 Months 23.12% | 1 Year 25.97% | 5 Years (CAGR)* -16.94% | 10 Years (CAGR)* 10.58% |
* Compound Annual Growth Rate
| Valuation | |||
|---|---|---|---|
| EPS (Rs)* 25.24 | P/E Ratio (x) 20.76 | Market Cap (Rs m) 31,259.58 | P/BV (x) 1.27 |
| *Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
- Charts
-
S&P BSE SENSEX 
PERIOD - Advanced Charts new
- Charts by TradingView
STRIDES PHARMA SCIENCE Share Price Today:
STRIDES PHARMA SCIENCE last traded price was down 0.2% to Rs 524.1 on the BSE. On the NSE, STRIDES PHARMA SCIENCE last traded price was down 0.3% to Rs 523.8. The total volume of shares traded was 2.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.3%. And the benchmark S&P BSE SENSEX was at 38,040.6 (up 0.0%).
Over the last 30 days, the STRIDES PHARMA SCIENCE share price is up 27.7%. And over the last one year, STRIDES PHARMA SCIENCE share price is up 26.0%.
What else is happening in the markets today? Dig in...
- TRACK NOW:
- Most Active Stocks Rs 0 to 10
- Most Active Stocks Rs 10 to 20
- BSE A Group Gainers Today
- NSE Above Rs 20 Gainers Today
- BSE Above Rs 20 Gainers Today
- BSE Sensex Gainers Today
- BSE Small Cap Gainers Today
- BSE 500 Gainers Today
- BSE A Group Losers Today
- Most Active Stocks Rs 1 to 2
- NSE Above Rs 20 Losers Today
- Buzzing Stocks Today
Today's Market
Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.
Related Views On News
STRIDES PHARMA SCIENCE Announces Quarterly Results (2QFY20); Net Profit Up 2778.7% (Quarterly Result Update)
Nov 1, 2019 | Updated on Nov 1, 2019For the quarter ended September 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (up 2778.7% YoY). Sales on the other hand came in at Rs 7 bn (down 2.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.
STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY20); Net Profit Up 1048.1% (Quarterly Result Update)
Jul 31, 2019 | Updated on Jul 31, 2019For the quarter ended June 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 432 m (up 1048.1% YoY). Sales on the other hand came in at Rs 7 bn (up 3.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.
STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)
Dec 19, 2018 | Updated on Dec 19, 2018Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.
More Views on NewsMost Popular
These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)
Jul 28, 2020When it comes to quality stocks, doing less is more.
Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)
Jul 29, 2020As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.
How to Buy Gold and Silver (Fast Profits Daily)
Jul 27, 2020In this video I'll show you how to buy bullion the right way.
Large Opportunities Are Coming Our Way
Aug 5, 2020Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.
MoreOUR TOP 5 IDEAS
- Free Report: Multibagger Stock Ideas 2020
- Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
- Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
- Free Report: The Secret to Increasing Your Trading Profits Daily!
- No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.
TRACK STRIDES PHARMA SCIENCE
- Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON STRIDES PHARMA SCIENCE
STRIDES PHARMA SCIENCE - ADCOCK INGRAM COMPARISON
COMPARE STRIDES PHARMA SCIENCE WITH
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.